Freenome
Making early-stage cancer detection effective.
Backed by
Raised $254M Series E on Feb 15, 2024
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.
Manager, Cost Accounting
Brisbane, California · Posted on Aug 26, 2025
Automation Engineer II
Brisbane, California · Posted on Aug 19, 2025
Staff Bioinformatics Research Engineer
Brisbane, California · Posted on Aug 5, 2025
Senior Development Scientist
Brisbane, California · Posted on Jul 21, 2025
Future Consideration
Brisbane, California · Posted on May 28, 2025
Senior Director, Market Access
Brisbane, California · Posted on May 28, 2025
Explore similar companies to Freenome
Assort Health
AI agents for healthcare call centers.
Stride
Portable benefits for small business.
Fabric
Intelligently connected care.
Thatch
Modern health benefits platform.
Junction
Modernizing healthcare infrastructure.
Anterior
Lead your health plan into the future.
Fortuna Health
Helping consumers navigate Medicaid.
Stedi
The only API-first healthcare clearinghouse.
Eternal
Longevity care for athletes.